blog

How hard are the major licensing exams, and when should you sit them? Pass rates and timing for the USMLE, PLAB and UKMLA, MCCQE, and AMC, why the headline pass rates hide the IMG ...

What licensing exams and preparation actually cost across the US, UK, Canada, and Australia, from registration fees to question banks and hidden extras. A market-by-market breakdow...

Your raw question-bank percentage is a weak, biased predictor of your real exam score. Timed self-assessments predict far better. What the correlation data shows for the USMLE, how...

Three months after launch, AMBOSS AI Mode Learning is a capable study copilot that turns questions and uploads into explanations, targeted practice, and next steps inside AMBOSS. W...

AMBOSS is worth it if you use the whole stack and value integrated learning, and less so if you only need targeted question practice. A cost-per-outcome review: what you pay relati...

International medical graduates often sit more than one licensing exam across countries. An honest comparison of AMBOSS and iatroX by destination, the one-subscription multi-countr...

AMBOSS offers a UKMLA study guide that maps the GMC content map onto its existing library and Qbank. An honest assessment of what that gives UK candidates, where US-origin content ...

AMBOSS costs what it costs because you are buying a bundle: a large medical library, an 11,000-plus question Qbank, AI features, an Anki add-on, a score predictor, and clinical too...

AMBOSS acquired Novaheal, the leading nursing-education platform in Germany, positioning itself across the two largest healthcare professions. What the deal signals about platform ...

AMBOSS acquired NEJM Knowledge+, the NEJM Group board review and CME tool for internal medicine, family medicine, and pediatrics, and folded it into its platform. What that means f...

AMBOSS raised €240 million, converted to a European stock corporation, and signalled a possible IPO. What a heavily capitalised incumbent optimises for, what it cannot easily do, a...

Medical devices are classified by risk, not sophistication, into Class I, IIa, IIb and III. A plain guide for clinicians: what the classes mean, the UKCA and EU MDR routes, why sof...